首页 > 最新文献

Spanish Journal of Psychiatry and Mental Health最新文献

英文 中文
Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder 辅助药物对双相情感障碍和药物使用障碍并发症的影响的元分析。
0 PSYCHIATRY Pub Date : 2024-10-01 DOI: 10.1016/j.rpsm.2023.01.005
Joaquim Radua , Lydia Fortea , José Manuel Goikolea , Iñaki Zorrilla , Miquel Bernardo , Manuel Arrojo , Ruth Cunill , Xavi Castells , Elisardo Becoña , Ana López-Durán , Marta Torrens , Judit Tirado-Muñoz , Francina Fonseca , Belén Arranz , Marina Garriga , Pilar A. Sáiz , Gerardo Flórez , Luis San , Ana González-Pinto

Background

Individuals with bipolar disorder (BD) often have co-occurring substance use disorders (SUDs), which substantially impoverish the course of illness. Despite the importance of this dual diagnosis, the evidence of the efficacy and safety of adjuvant treatments is mostly unknown.

Objective

To perform a meta-analysis to evaluate the efficacy and safety of adjuvant drugs in patients with co-occurring BD and SUD.

Methods

We searched PubMed, Scopus, and Web of Knowledge until 30th April 2022 for randomized clinical trials (RCT) evaluating the efficacy and safety of adjuvant drugs compared to placebo in patients with a dual diagnosis of BD and SUD. We meta-analyzed the effect of adjuvant drugs on general outcomes (illness severity, mania, depression, anxiety, abstinence, substance craving, substance use, gamma-GT, adherence, and adverse events) and used the results to objectively assess the quality of the evidence according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. For completeness, we also report the specific effects of specific adjuvant drugs in patients with specific substance disorders.

Results

We included 15 RCT studies (9 alcohol, 3 cocaine, 2 nicotine, and 1 cannabis) comprising 628 patients allocated to treatment and 622 to placebo. There was low-quality evidence that adjuvant drugs may reduce illness severity (g = −0.25, 95% CI: −0.44, −0.06), and very-low quality evidence that they may decrease substance use (g = −0.23, 95% CI: −0.44, −0.02) and increase substance abstinence (g = 0.21, 95% CI: 0.04, 0.38).

Discussion

There is low-quality evidence that adjuvant drugs may help reduce illness severity, probably via facilitating abstinence and lower substance use. However, the evidence is weak; thus, these results should be considered cautiously until better evidence exists.
背景:双相情感障碍(BD)患者通常同时患有药物使用障碍(SUD),这严重影响了患者的病程。尽管这种双重诊断非常重要,但辅助治疗的疗效和安全性证据却大多不详:目的:进行一项荟萃分析,评估辅助药物对并发 BD 和 SUD 患者的疗效和安全性:截至2022年4月30日,我们在PubMed、Scopus和Web of Knowledge上检索了评估辅助药物与安慰剂相比对BD和SUD双重诊断患者疗效和安全性的随机临床试验(RCT)。我们对辅助药物对一般结果(疾病严重程度、躁狂、抑郁、焦虑、戒断、药物渴求、药物使用、γ-GT、依从性和不良事件)的影响进行了荟萃分析,并根据建议评估、发展和评价分级法(GRADE)对结果进行了客观的证据质量评估。为完整起见,我们还报告了特定辅助药物对特定药物紊乱患者的具体效果:我们纳入了 15 项 RCT 研究(9 项酒精研究、3 项可卡因研究、2 项尼古丁研究和 1 项大麻研究),其中 628 名患者接受了治疗,622 名患者接受了安慰剂治疗。低质量证据表明,辅助药物可降低疾病的严重程度(g=-0.25,95% CI:-0.44,-0.06),极低质量证据表明,辅助药物可减少药物使用(g=-0.23,95% CI:-0.44,-0.02)并提高药物戒断率(g=0.21,95% CI:0.04,0.38):有低质量的证据表明,辅助药物可能有助于降低疾病的严重程度,这可能是通过促进戒断和减少药物使用来实现的。然而,这些证据还很薄弱;因此,在有更好的证据之前,应谨慎考虑这些结果。
{"title":"Meta-analysis of the effects of adjuvant drugs in co-occurring bipolar and substance use disorder","authors":"Joaquim Radua ,&nbsp;Lydia Fortea ,&nbsp;José Manuel Goikolea ,&nbsp;Iñaki Zorrilla ,&nbsp;Miquel Bernardo ,&nbsp;Manuel Arrojo ,&nbsp;Ruth Cunill ,&nbsp;Xavi Castells ,&nbsp;Elisardo Becoña ,&nbsp;Ana López-Durán ,&nbsp;Marta Torrens ,&nbsp;Judit Tirado-Muñoz ,&nbsp;Francina Fonseca ,&nbsp;Belén Arranz ,&nbsp;Marina Garriga ,&nbsp;Pilar A. Sáiz ,&nbsp;Gerardo Flórez ,&nbsp;Luis San ,&nbsp;Ana González-Pinto","doi":"10.1016/j.rpsm.2023.01.005","DOIUrl":"10.1016/j.rpsm.2023.01.005","url":null,"abstract":"<div><h3>Background</h3><div>Individuals with bipolar disorder<span> (BD) often have co-occurring substance use disorders (SUDs), which substantially impoverish the course of illness. Despite the importance of this dual diagnosis, the evidence of the efficacy and safety of adjuvant treatments is mostly unknown.</span></div></div><div><h3>Objective</h3><div>To perform a meta-analysis to evaluate the efficacy and safety of adjuvant drugs in patients with co-occurring BD and SUD.</div></div><div><h3>Methods</h3><div>We searched PubMed, Scopus, and Web of Knowledge until 30th April 2022 for randomized clinical trials<span> (RCT) evaluating the efficacy and safety of adjuvant drugs compared to placebo in patients with a dual diagnosis of BD and SUD. We meta-analyzed the effect of adjuvant drugs on general outcomes (illness severity, mania, depression, anxiety, abstinence, substance craving, substance use, gamma-GT, adherence, and adverse events) and used the results to objectively assess the quality of the evidence according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. For completeness, we also report the specific effects of specific adjuvant drugs in patients with specific substance disorders.</span></div></div><div><h3>Results</h3><div>We included 15 RCT studies (9 alcohol, 3 cocaine, 2 nicotine, and 1 cannabis) comprising 628 patients allocated to treatment and 622 to placebo. There was low-quality evidence that adjuvant drugs may reduce illness severity (<em>g</em> <!-->=<!--> <!-->−0.25, 95% CI: −0.44, −0.06), and very-low quality evidence that they may decrease substance use (<em>g</em> <!-->=<!--> <!-->−0.23, 95% CI: −0.44, −0.02) and increase substance abstinence (<em>g</em> <!-->=<!--> <!-->0.21, 95% CI: 0.04, 0.38).</div></div><div><h3>Discussion</h3><div>There is low-quality evidence that adjuvant drugs may help reduce illness severity, probably via facilitating abstinence and lower substance use. However, the evidence is weak; thus, these results should be considered cautiously until better evidence exists.</div></div>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":"17 4","pages":"Pages 239-250"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10181957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional Remediation for Older Adults with Bipolar Disorder (FROA-BD): Study protocol for a randomized controlled trial 双相情感障碍老年人功能补救(FROA-BD):随机对照试验研究方案
0 PSYCHIATRY Pub Date : 2024-10-01 DOI: 10.1016/j.rpsm.2022.01.004
Laura Montejo , Esther Jiménez , Carla Torrent , Caterina del Mar Bonnín , Brisa Solé , Anabel Martínez-Arán , Eduard Vieta , Jose Sánchez Moreno

Background

Older Adults with Bipolar Disorder (OABD) show cognitive impairments with a negative impact on psychosocial functioning and quality of life. However, to date any intervention for the improvement of functioning has been developed for OABD. The current project aims to demonstrate the efficacy of the Functional Remediation program (FR) specifically adapted to OABD, over 60 years old, for improving functional outcome.

Methods

This is an experimental, randomized-controlled trial. Two groups will be included: the experimental group (n = 42) will receive a 4-month intervention consisting of 32 sessions of treatment and the control group which will receive treatment as usual (TAU) (n = 42). The intervention will result from the adaptation of the Functional Remediation program for OABD (FROA-BD), that has already proven its efficacy at improving psychosocial functioning in patients with bipolar disorder. Clinical, neuropsychological and functional evaluations will be carried out at baseline, post-intervention and follow-up (one year after baseline evaluation). We hypothesized that patients who have undergone the intervention FROA-BD will improve their psychosocial functioning, cognitive performance, quality of life and well-being. We also hypothesized that all these changes will remain stable after eight month follow-up.

Conclusions

The results will provide evidence of the efficacy in improving psychosocial functioning, cognitive performance and quality of life applying the FROA-BD. This project consists in the first attempt to adapt the FR program to OABD population who needs specific needs and approaches. The novelty of this contribution represents an advance in the framework of psychological treatment in later-life bipolar disorder.
背景老年双相情感障碍(OABD)表现出认知障碍,对心理社会功能和生活质量产生负面影响。然而,迄今为止,还没有针对躁狂症老年患者的改善功能的干预措施。本项目旨在证明专门针对 60 岁以上 OABD 患者的功能补救计划(FR)对改善功能结果的有效性。试验分为两组:实验组(42 人)将接受为期 4 个月的干预,包括 32 个疗程的治疗;对照组(42 人)将接受常规治疗(TAU)。干预措施将采用 "躁狂症功能性补救方案"(FROA-BD),该方案已被证明能有效改善躁狂症患者的社会心理功能。临床、神经心理学和功能评估将在基线、干预后和随访(基线评估后一年)时进行。我们假设,接受 FROA-BD 干预的患者将改善其社会心理功能、认知能力、生活质量和幸福感。我们还假设,在八个月的随访后,所有这些变化都将保持稳定。结论结果将为应用 FROA-BD 改善心理社会功能、认知能力和生活质量的有效性提供证据。该项目是首次尝试将心理康复计划适用于需要特殊需求和方法的 OABD 患者。这一贡献的新颖性代表了晚年双相情感障碍心理治疗框架的进步。
{"title":"Functional Remediation for Older Adults with Bipolar Disorder (FROA-BD): Study protocol for a randomized controlled trial","authors":"Laura Montejo ,&nbsp;Esther Jiménez ,&nbsp;Carla Torrent ,&nbsp;Caterina del Mar Bonnín ,&nbsp;Brisa Solé ,&nbsp;Anabel Martínez-Arán ,&nbsp;Eduard Vieta ,&nbsp;Jose Sánchez Moreno","doi":"10.1016/j.rpsm.2022.01.004","DOIUrl":"10.1016/j.rpsm.2022.01.004","url":null,"abstract":"<div><h3>Background</h3><div>Older Adults with Bipolar Disorder (OABD) show cognitive impairments with a negative impact on psychosocial functioning and quality of life. However, to date any intervention for the improvement of functioning has been developed for OABD. The current project aims to demonstrate the efficacy of the Functional Remediation program (FR) specifically adapted to OABD, over 60 years old, for improving functional outcome.</div></div><div><h3>Methods</h3><div>This is an experimental, randomized-controlled trial. Two groups will be included: the experimental group (<em>n</em> <!-->=<!--> <!-->42) will receive a 4-month intervention consisting of 32 sessions of treatment and the control group which will receive treatment as usual (TAU) (<em>n</em> <!-->=<!--> <!-->42). The intervention will result from the adaptation of the Functional Remediation program for OABD (FROA-BD), that has already proven its efficacy at improving psychosocial functioning in patients with bipolar disorder. Clinical, neuropsychological and functional evaluations will be carried out at baseline, post-intervention and follow-up (one year after baseline evaluation). We hypothesized that patients who have undergone the intervention FROA-BD will improve their psychosocial functioning, cognitive performance, quality of life and well-being. We also hypothesized that all these changes will remain stable after eight month follow-up.</div></div><div><h3>Conclusions</h3><div>The results will provide evidence of the efficacy in improving psychosocial functioning, cognitive performance and quality of life applying the FROA-BD. This project consists in the first attempt to adapt the FR program to OABD population who needs specific needs and approaches. The novelty of this contribution represents an advance in the framework of psychological treatment in later-life bipolar disorder.</div></div>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":"17 4","pages":"Pages 181-189"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91349231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering the future of psychiatry: The development of the young psychiatrists section of the Spanish Society of Psychiatry and Mental Health. 为精神病学的未来赋权:西班牙精神病学和心理健康学会青年精神病学家分会的发展。
0 PSYCHIATRY Pub Date : 2024-09-24 DOI: 10.1016/j.sjpmh.2024.09.003
Gonzalo Salazar de Pablo, Claudia Aymerich, Justo Pinzón-Espinosa
{"title":"Empowering the future of psychiatry: The development of the young psychiatrists section of the Spanish Society of Psychiatry and Mental Health.","authors":"Gonzalo Salazar de Pablo, Claudia Aymerich, Justo Pinzón-Espinosa","doi":"10.1016/j.sjpmh.2024.09.003","DOIUrl":"10.1016/j.sjpmh.2024.09.003","url":null,"abstract":"","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Luis Martín-Santos: A multidimensional psychiatrist. "路易斯-马丁-桑托斯:多维精神病学家"。
0 PSYCHIATRY Pub Date : 2024-09-21 DOI: 10.1016/j.sjpmh.2024.09.002
José Lázaro
{"title":"Luis Martín-Santos: A multidimensional psychiatrist.","authors":"José Lázaro","doi":"10.1016/j.sjpmh.2024.09.002","DOIUrl":"10.1016/j.sjpmh.2024.09.002","url":null,"abstract":"","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders. 个体化测试前风险评估,为临床高危精神病患者的治疗决策提供指导。
0 PSYCHIATRY Pub Date : 2024-09-18 DOI: 10.1016/j.sjpmh.2024.09.001
Elodie Sprüngli-Toffel, Erich Studerus, Logos Curtis, Caroline Conchon, Luis Alameda, Barbara Bailey, Camille Caron, Carmina Haase, Julia Gros, Evelyn Herbrecht, Christian G Huber, Anita Riecher-Rössler, Philippe Conus, Alessandra Solida, Marco Armando, Afroditi Kapsaridi, Mathieu Mercapide Ducommun, Paul Klauser, Kerstin Jessica Plessen, Sébastien Urben, Anne Edan, Nathalie Nanzer, Ana Liso Navarro, Maude Schneider, Davina Genoud, Chantal Michel, Jochen Kindler, Michael Kaess, Dominic Oliver, Paolo Fusar-Poli, Stefan Borgwardt, Christina Andreou

Introduction: Clinical high risk for psychosis (CHR) states are associated with an increased risk of transition to psychosis. However, the predictive value of CHR screening interviews is dependent on pretest risk enrichment in referred patients. This poses a major obstacle to CHR outreach campaigns since they invariably lead to risk dilution through enhanced awareness. A potential compensatory strategy is to use estimates of individual pretest risk as a 'gatekeeper' for specialized assessment. We aimed to test a risk stratification model previously developed in London, UK (OASIS) and to train a new predictive model for the Swiss population.

Method: The sample was composed of 513 individuals referred for CHR assessment from six Swiss early psychosis detection services. Sociodemographic variables available at referral were used as predictors whereas the outcome variable was transition to psychosis.

Results: Replication of the risk stratification model developed in OASIS resulted in poor performance (Harrel's c=0.51). Retraining resulted in moderate discrimination (Harrel's c=0.67) which significantly differentiated between different risk groups. The lowest risk group had a cumulative transition incidence of 6.4% (CI: 0-23.1%) over two years.

Conclusion: Failure to replicate the OASIS risk stratification model might reflect differences in the public health care systems and referral structures between Switzerland and London. Retraining resulted in a model with adequate discrimination performance. The developed model in combination with CHR assessment result, might be useful for identifying individuals with high pretest risk, who might benefit most from specialized intervention.

导言:临床精神病高风险(CHR)状态与转为精神病的风险增加有关。然而,CHR 筛查面谈的预测价值取决于转介患者测试前的风险富集情况。这对 CHR 外展活动构成了重大障碍,因为这些活动总会通过提高认知度来稀释风险。一种潜在的补偿策略是使用个人检测前风险估计值作为专门评估的 "守门员"。我们的目的是测试之前在英国伦敦开发的风险分层模型(OASIS),并为瑞士人群训练一个新的预测模型:样本由瑞士六家早期精神病检测服务机构转介的 513 名接受 CHR 评估者组成。转介时的社会人口学变量被用作预测因子,而结果变量则是向精神病的转变:结果:复制在 OASIS 中开发的风险分层模型的效果不佳(Harrel's c = 0.51)。重新训练的结果是中度区分度(Harrel's c = 0.67),显著区分了不同的风险组别。最低风险组在两年内的累计转换发生率为 6.4% (CI: 0% - 23.1%):未能复制OASIS风险分层模型可能反映了瑞士和伦敦在公共医疗系统和转诊结构上的差异。重新训练后的模型具有足够的识别性能。所开发的模型与CHR评估结果相结合,可能有助于识别检测前风险较高的个体,这些个体可能从专门干预中获益最多。
{"title":"Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders.","authors":"Elodie Sprüngli-Toffel, Erich Studerus, Logos Curtis, Caroline Conchon, Luis Alameda, Barbara Bailey, Camille Caron, Carmina Haase, Julia Gros, Evelyn Herbrecht, Christian G Huber, Anita Riecher-Rössler, Philippe Conus, Alessandra Solida, Marco Armando, Afroditi Kapsaridi, Mathieu Mercapide Ducommun, Paul Klauser, Kerstin Jessica Plessen, Sébastien Urben, Anne Edan, Nathalie Nanzer, Ana Liso Navarro, Maude Schneider, Davina Genoud, Chantal Michel, Jochen Kindler, Michael Kaess, Dominic Oliver, Paolo Fusar-Poli, Stefan Borgwardt, Christina Andreou","doi":"10.1016/j.sjpmh.2024.09.001","DOIUrl":"10.1016/j.sjpmh.2024.09.001","url":null,"abstract":"<p><strong>Introduction: </strong>Clinical high risk for psychosis (CHR) states are associated with an increased risk of transition to psychosis. However, the predictive value of CHR screening interviews is dependent on pretest risk enrichment in referred patients. This poses a major obstacle to CHR outreach campaigns since they invariably lead to risk dilution through enhanced awareness. A potential compensatory strategy is to use estimates of individual pretest risk as a 'gatekeeper' for specialized assessment. We aimed to test a risk stratification model previously developed in London, UK (OASIS) and to train a new predictive model for the Swiss population.</p><p><strong>Method: </strong>The sample was composed of 513 individuals referred for CHR assessment from six Swiss early psychosis detection services. Sociodemographic variables available at referral were used as predictors whereas the outcome variable was transition to psychosis.</p><p><strong>Results: </strong>Replication of the risk stratification model developed in OASIS resulted in poor performance (Harrel's c=0.51). Retraining resulted in moderate discrimination (Harrel's c=0.67) which significantly differentiated between different risk groups. The lowest risk group had a cumulative transition incidence of 6.4% (CI: 0-23.1%) over two years.</p><p><strong>Conclusion: </strong>Failure to replicate the OASIS risk stratification model might reflect differences in the public health care systems and referral structures between Switzerland and London. Retraining resulted in a model with adequate discrimination performance. The developed model in combination with CHR assessment result, might be useful for identifying individuals with high pretest risk, who might benefit most from specialized intervention.</p>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study. 减轻焦虑和抑郁症状的应对行为:一项前瞻性重复评估研究。
N/A PSYCHIATRY Pub Date : 2024-09-01 DOI: 10.1016/j.sjpmh.2024.08.003
Lydia Fortea, Aleix Solanes, Edith Pomarol-Clotet, Maria Angeles Garcia-Leon, Adriana Fortea, Carla Torrent, Cristina Varo, Caterina Del Mar Bonnin, Laura Montejo, Jordi Alonso, Susana Carmona, Pau Soldevila-Matías, Irene Alustiza, Daniel Arbós, Diego Hidalgo-Mazzei, Iria Grande, Eduard Vieta, Miquel Àngel Fullana, Joaquim Radua

Introduction: Health institutions provide general recommendations to cope with global crises such as pandemics or geopolitical tensions. However, these recommendations are mainly based on cross-sectional evidence. The preregistered Repeated Assessment of Behaviors and Symptoms in the Population (RABSYPO) study sought to establish prospective longitudinal evidence from a cohort with a demographic distribution similar to that of the Spanish population to provide evidence for developing solid universal recommendations to reduce anxiety and depressive symptoms during times of uncertainty.

Material and methods: We first recruited via social networks a pool of Spanish individuals willing to participate and then randomly selected some within each stratum of age×gender×region×urbanicity to conduct a one-year-long bi-weekly online follow-up about the frequency of ten simple potential coping behaviors as well as anxiety (GAD-7) and depressive symptoms (PHQ-9). Mixed-effects autoregressive moving average models were used to analyze the relationship between past behaviors' frequency and subsequent symptom changes across the twenty-seven time points.

Results: Among the 1049 who started the follow-up, 942 completed it and were included in the analyses. Avoiding excessive exposure to distressing news and maintaining a healthy/balanced diet, followed by spending time outdoors and physical exercise, were the coping behaviors most strongly associated with short and long-term reductions of anxiety and depressive symptoms. Engaging in relaxing activities and drinking water to hydrate were only associated with short-term symptom reductions. Socializing was associated with symptom reductions in the long term.

Conclusions: This study provides compelling prospective evidence that adopting a set of simple coping behaviors is associated with small but significant reductions in anxiety and depressive symptoms during times of uncertainty. It also includes a layman's summary of this evidence to help develop general recommendations that serve as universal tools for enhancing mental health and well-being.

导言:卫生机构为应对大流行病或地缘政治紧张局势等全球性危机提供了一般性建议。然而,这些建议主要基于横断面证据。预先登记的《人群行为和症状重复评估》(RABSYPO)研究试图从与西班牙人口分布相似的人群中建立前瞻性纵向证据,为制定可靠的通用建议提供证据,以减少不确定时期的焦虑和抑郁症状:我们首先通过社交网络招募了一批愿意参与的西班牙人,然后在年龄 X 性别 X 地区 X 城市的每个阶层中随机挑选了一些人,就十种简单的潜在应对行为的频率以及焦虑(GAD-7)和抑郁症状(PHQ-9)进行了为期一年的双周在线随访。研究采用混合效应自回归移动平均模型分析了过去行为频率与随后二十七个时间点症状变化之间的关系:在开始随访的 1049 人中,有 942 人完成了随访并纳入了分析。避免过多接触令人痛苦的新闻和保持健康/均衡的饮食,其次是户外活动和体育锻炼,这些应对行为与焦虑和抑郁症状的短期和长期缓解关系最为密切。参与放松活动和喝水补充水分只与短期症状减轻有关。社交与症状的长期缓解有关:本研究提供了令人信服的前瞻性证据,表明在不确定时期,采取一系列简单的应对行为与焦虑和抑郁症状轻微但显著的减轻有关。研究还对这些证据进行了通俗易懂的总结,以帮助制定一般性建议,作为增进心理健康和幸福感的通用工具。
{"title":"Coping behaviors to reduce anxiety and depressive symptoms: A prospective repeated assessment study.","authors":"Lydia Fortea, Aleix Solanes, Edith Pomarol-Clotet, Maria Angeles Garcia-Leon, Adriana Fortea, Carla Torrent, Cristina Varo, Caterina Del Mar Bonnin, Laura Montejo, Jordi Alonso, Susana Carmona, Pau Soldevila-Matías, Irene Alustiza, Daniel Arbós, Diego Hidalgo-Mazzei, Iria Grande, Eduard Vieta, Miquel Àngel Fullana, Joaquim Radua","doi":"10.1016/j.sjpmh.2024.08.003","DOIUrl":"10.1016/j.sjpmh.2024.08.003","url":null,"abstract":"<p><strong>Introduction: </strong>Health institutions provide general recommendations to cope with global crises such as pandemics or geopolitical tensions. However, these recommendations are mainly based on cross-sectional evidence. The preregistered Repeated Assessment of Behaviors and Symptoms in the Population (RABSYPO) study sought to establish prospective longitudinal evidence from a cohort with a demographic distribution similar to that of the Spanish population to provide evidence for developing solid universal recommendations to reduce anxiety and depressive symptoms during times of uncertainty.</p><p><strong>Material and methods: </strong>We first recruited via social networks a pool of Spanish individuals willing to participate and then randomly selected some within each stratum of age×gender×region×urbanicity to conduct a one-year-long bi-weekly online follow-up about the frequency of ten simple potential coping behaviors as well as anxiety (GAD-7) and depressive symptoms (PHQ-9). Mixed-effects autoregressive moving average models were used to analyze the relationship between past behaviors' frequency and subsequent symptom changes across the twenty-seven time points.</p><p><strong>Results: </strong>Among the 1049 who started the follow-up, 942 completed it and were included in the analyses. Avoiding excessive exposure to distressing news and maintaining a healthy/balanced diet, followed by spending time outdoors and physical exercise, were the coping behaviors most strongly associated with short and long-term reductions of anxiety and depressive symptoms. Engaging in relaxing activities and drinking water to hydrate were only associated with short-term symptom reductions. Socializing was associated with symptom reductions in the long term.</p><p><strong>Conclusions: </strong>This study provides compelling prospective evidence that adopting a set of simple coping behaviors is associated with small but significant reductions in anxiety and depressive symptoms during times of uncertainty. It also includes a layman's summary of this evidence to help develop general recommendations that serve as universal tools for enhancing mental health and well-being.</p>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A psychiatrist in the court of Philip II of Spain: Mental medicine in the work of Francisco Valles (1524-1592). 西班牙腓力二世宫廷中的精神病医生:弗朗西斯科-瓦莱斯(1524-1592 年)作品中的精神医学。
N/A PSYCHIATRY Pub Date : 2024-08-24 DOI: 10.1016/j.sjpmh.2024.08.001
David Fraguas
{"title":"A psychiatrist in the court of Philip II of Spain: Mental medicine in the work of Francisco Valles (1524-1592).","authors":"David Fraguas","doi":"10.1016/j.sjpmh.2024.08.001","DOIUrl":"10.1016/j.sjpmh.2024.08.001","url":null,"abstract":"","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in the impact of suicide compared to other external causes of death: From 1995 to 2020. 自杀与其他外部死因相比的影响趋势:1995 至 2020 年。
N/A PSYCHIATRY Pub Date : 2024-07-24 DOI: 10.1016/j.sjpmh.2024.07.004
Jimena María Merayo-Cano, Alejandro Porras-Segovia, Santiago Ovejero-Garcia, Enrique Baca-García

Background: Suicide is one of the world's greatest public health problems. More than 700,000 people lose their lives to suicide every year. While funding for mental health waits to be increased, thousands of suicides occur every day.

Material and methods: This study aims to quantify the global impact of suicide compared to other external causes of death in terms of years of potential life lost (YPLL), and how this will change between 1995 and 2020. Our source of information is the World Health Organization (WHO) mortality database. We then use YPLL, a standard measure of premature mortality and burden of disease that brings precision to the assessment of the impact of different causes of death. This, combined with the compound annual growth rate (CAGR) as a way of expressing increase, gives us a better understanding of the real situation and trends of suicide compared to other external causes of death in different countries worldwide.

Results: Based on the available sources of information and the selection criteria, we obtained a sample of 69 countries. The CAGR for all causes per capita decreased over the observed period in 65 countries, and it increases in 4 countries. In contrast, the CAGR specifically for suicide decreased in 49 countries, while an increase was observed in 20 countries.

Conclusions: Prevention of most external causes of mortality shows promising data in most countries. However, this is not the case for suicide. Thus, YPLL due to suicide have decreased to a comparatively lesser extent and have even increased in some countries, a very worrying situation that poses many clinical and epidemiological challenges.

背景:自杀是世界上最大的公共卫生问题之一。每年有 70 多万人死于自杀。虽然心理健康方面的资金有待增加,但每天都有成千上万人自杀:本研究旨在量化自杀与其他外部死因相比对全球造成的潜在生命损失年数(YPLL)影响,以及这种影响在 1995 年至 2020 年间的变化情况。我们的信息来源是世界卫生组织(WHO)的死亡率数据库。然后,我们使用 "潜在生命损失年数"(YPLL),这是衡量过早死亡率和疾病负担的标准,可精确评估不同死因的影响。结合复合年增长率(CAGR)这一表示增长的方法,我们可以更好地了解自杀与世界各国其他外部死因相比的真实情况和趋势:根据现有的信息来源和选择标准,我们获得了 69 个国家的样本。在观察期内,65 个国家的所有人均死因的年均复合增长率有所下降,4 个国家的年均复合增长率有所上升。相比之下,49 个国家自杀死亡率的年均复合增长率下降,20 个国家上升:结论:大多数国家在预防大多数外部致死原因方面都取得了可喜的数据。然而,自杀的情况并非如此。因此,自杀导致的青年死亡率下降幅度相对较小,在一些国家甚至有所上升,这种情况非常令人担忧,给临床和流行病学带来了许多挑战。
{"title":"Trends in the impact of suicide compared to other external causes of death: From 1995 to 2020.","authors":"Jimena María Merayo-Cano, Alejandro Porras-Segovia, Santiago Ovejero-Garcia, Enrique Baca-García","doi":"10.1016/j.sjpmh.2024.07.004","DOIUrl":"10.1016/j.sjpmh.2024.07.004","url":null,"abstract":"<p><strong>Background: </strong>Suicide is one of the world's greatest public health problems. More than 700,000 people lose their lives to suicide every year. While funding for mental health waits to be increased, thousands of suicides occur every day.</p><p><strong>Material and methods: </strong>This study aims to quantify the global impact of suicide compared to other external causes of death in terms of years of potential life lost (YPLL), and how this will change between 1995 and 2020. Our source of information is the World Health Organization (WHO) mortality database. We then use YPLL, a standard measure of premature mortality and burden of disease that brings precision to the assessment of the impact of different causes of death. This, combined with the compound annual growth rate (CAGR) as a way of expressing increase, gives us a better understanding of the real situation and trends of suicide compared to other external causes of death in different countries worldwide.</p><p><strong>Results: </strong>Based on the available sources of information and the selection criteria, we obtained a sample of 69 countries. The CAGR for all causes per capita decreased over the observed period in 65 countries, and it increases in 4 countries. In contrast, the CAGR specifically for suicide decreased in 49 countries, while an increase was observed in 20 countries.</p><p><strong>Conclusions: </strong>Prevention of most external causes of mortality shows promising data in most countries. However, this is not the case for suicide. Thus, YPLL due to suicide have decreased to a comparatively lesser extent and have even increased in some countries, a very worrying situation that poses many clinical and epidemiological challenges.</p>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141768419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cibersam: A change in the paradigm of mental health research in Spain. CIBERSAM:西班牙心理健康研究范式的变革。
N/A PSYCHIATRY Pub Date : 2024-07-22 DOI: 10.1016/j.sjpmh.2024.07.003
Celso Arango, Eduard Vieta
{"title":"Cibersam: A change in the paradigm of mental health research in Spain.","authors":"Celso Arango, Eduard Vieta","doi":"10.1016/j.sjpmh.2024.07.003","DOIUrl":"10.1016/j.sjpmh.2024.07.003","url":null,"abstract":"","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141763926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altered activation of the dorsal anterior cingulate cortex during oddball performance in individuals at risk for Alzheimer's disease. 阿尔茨海默氏症高危人群在玩古怪球时背侧前扣带回皮层的激活发生变化。
N/A PSYCHIATRY Pub Date : 2024-07-09 DOI: 10.1016/j.sjpmh.2024.07.001
Pamela Chavarría-Elizondo, Carla Del Río-Torné, Pablo Maturana-Quijada, Ignacio Martínez-Zalacaín, Asier Juaneda, Inés Del Cerro, Andrés Guinea-Izquierdo, Jordi Gascón-Bayarri, Ramón Reñé-Ramírez, Mikel Urretavizcaya, Isidre Ferrer, José M Menchón, Virginia Soria, Carles Soriano-Mas

Introduction: The neural mechanisms underlying neurodegenerative disorders in the elderly remain elusive, despite extensive neuroimaging research in recent decades. Amnestic type mild cognitive impairment (aMCI) and late-life major depressive disorder (MDD) are two such conditions characterized by intersecting cognitive and affective symptomatology, and they are at a higher risk for Alzheimer's disease.

Materials and methods: This study analyzed the neural underpinnings of cognitive and depressive symptoms in a cohort comprising 12 aMCI subjects, 24 late-life MDD patients, and 26 healthy controls (HCs). Participants underwent a detailed neuropsychological assessment and completed a visual attentional oddball task during functional magnetic resonance imaging (fMRI), with evaluations at baseline and at 2-year follow-up.

Results: Initial findings showed that aMCI subjects had reduced dACC activation during oddball (target) stimulus detection, a pattern that persisted in longitudinal analyses and correlated with cognitive functioning measures. For HCs, subsequent dACC activation was linked to depression scores. Furthermore, in the affective-cognitive altered groups, later dACC activation correlated with oddball and memory performance.

Conclusions: These findings enhance our comprehension of the neurobiological basis of cognitive and depressive disturbances in aging, indicating that dACC activation in response to a visual attentional oddball task could serve as a neural marker for assessing cognitive impairment and depression in conditions predisposing to Alzheimer's disease.

导言:尽管近几十年来进行了广泛的神经影像学研究,但老年神经退行性疾病的神经机制仍然难以捉摸。失忆型轻度认知障碍(aMCI)和晚年重度抑郁障碍(MDD)就是这样两种以认知和情感症状相互交织为特征的疾病,它们罹患阿尔茨海默病的风险较高:本研究分析了由12名阿尔茨海默病(aMCI)受试者、24名晚期MDD患者和26名健康对照者(HCs)组成的队列中认知和抑郁症状的神经基础。受试者接受了详细的神经心理学评估,并在功能磁共振成像(fMRI)期间完成了一项视觉注意力奇异任务,评估结果在基线和两年随访期间进行:初步研究结果表明,aMCI 受试者在检测奇异球(目标)刺激时,dACC 激活减少,这种模式在纵向分析中持续存在,并与认知功能测量相关。对于高危人群,随后的dACC激活与抑郁评分相关。此外,在情感-认知改变组中,随后的dACC激活与奇数和记忆表现相关:这些发现加深了我们对衰老过程中认知障碍和抑郁障碍的神经生物学基础的理解,表明对视觉注意力怪球任务做出反应的dACC激活可作为一种神经标志物,用于评估阿尔茨海默病易患人群的认知障碍和抑郁状况。
{"title":"Altered activation of the dorsal anterior cingulate cortex during oddball performance in individuals at risk for Alzheimer's disease.","authors":"Pamela Chavarría-Elizondo, Carla Del Río-Torné, Pablo Maturana-Quijada, Ignacio Martínez-Zalacaín, Asier Juaneda, Inés Del Cerro, Andrés Guinea-Izquierdo, Jordi Gascón-Bayarri, Ramón Reñé-Ramírez, Mikel Urretavizcaya, Isidre Ferrer, José M Menchón, Virginia Soria, Carles Soriano-Mas","doi":"10.1016/j.sjpmh.2024.07.001","DOIUrl":"10.1016/j.sjpmh.2024.07.001","url":null,"abstract":"<p><strong>Introduction: </strong>The neural mechanisms underlying neurodegenerative disorders in the elderly remain elusive, despite extensive neuroimaging research in recent decades. Amnestic type mild cognitive impairment (aMCI) and late-life major depressive disorder (MDD) are two such conditions characterized by intersecting cognitive and affective symptomatology, and they are at a higher risk for Alzheimer's disease.</p><p><strong>Materials and methods: </strong>This study analyzed the neural underpinnings of cognitive and depressive symptoms in a cohort comprising 12 aMCI subjects, 24 late-life MDD patients, and 26 healthy controls (HCs). Participants underwent a detailed neuropsychological assessment and completed a visual attentional oddball task during functional magnetic resonance imaging (fMRI), with evaluations at baseline and at 2-year follow-up.</p><p><strong>Results: </strong>Initial findings showed that aMCI subjects had reduced dACC activation during oddball (target) stimulus detection, a pattern that persisted in longitudinal analyses and correlated with cognitive functioning measures. For HCs, subsequent dACC activation was linked to depression scores. Furthermore, in the affective-cognitive altered groups, later dACC activation correlated with oddball and memory performance.</p><p><strong>Conclusions: </strong>These findings enhance our comprehension of the neurobiological basis of cognitive and depressive disturbances in aging, indicating that dACC activation in response to a visual attentional oddball task could serve as a neural marker for assessing cognitive impairment and depression in conditions predisposing to Alzheimer's disease.</p>","PeriodicalId":101179,"journal":{"name":"Spanish Journal of Psychiatry and Mental Health","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Spanish Journal of Psychiatry and Mental Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1